Artificial pancreas hope for diabetics "by 2018"

Doctors and engineers at the University of Cambridge expect an artificial pancreas device to relieve the symptoms of type-1 diabetes to be available by 2018.

The researchers, part of an ‘artificial pancreas consortium’ at the university, have made progress on integrating an insulin pump mechanism with a continuous blood-glucose monitoring system, a feat which has so far seemed to be an insurmountable problem.

An artificial pancreas would make life significantly easier for people suffering from type-1 diabetes, the variant of the disease where the body produces no insulin of its own.

Currently, sufferers have to test the level of glucose in their blood several times per day by pricking a finger and feeding a drop of blood into a hand-held meter; they must then calculate how much insulin they need to inject based on what they have been eating, how active they expect to be and several other factors. This means that their insulin requirements can vary widely: one day they might get through three times their average dosage, the next day only a third of it. Getting the dosage wrong risks hypo- or hyperglycaemia (too little or too much sugar), both of which cause cumulative damage to nerves and blood vessels.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox